Services

From a fast snapshot to a published authority page.

Each service applies the same HDDT engine at a different depth. Start where your decision requires it — a focused read, a full diligence narrative, a durable web asset, or a comparator landscape.

Service menu

Choose the right depth

All services deliver human-reviewed, source-linked conclusions. They differ in scope and in what you can do with the output.

HDDT Snapshot

Best for

Founders, angels, accelerators, and early-stage diligence.

A focused test of 5–8 core claims behind a company, technology, or investment thesis.

Deliverables

  • Hypothesis table
  • Evidence-for / evidence-against summary
  • Citation appendix
  • Investor-readiness conclusion
  • Priority diligence questions

Investor-Readiness HDDT

Best for

Seed-stage biotech companies preparing for investor conversations.

A full diligence narrative that tests the claims investors need to believe before funding the next milestone.

Deliverables

  • Biology feasibility analysis
  • Translational maturity review
  • Comparator failure map
  • Financeability analysis
  • Milestone realism assessment
  • Investor-facing authority report

Diligence-as-Authority Page

Best for

Biotech companies, funds, university spinouts, and regional innovation groups.

A published web asset that turns diligence into a durable, citation-backed, machine-readable authority page.

Deliverables

  • Structured Next.js authority page
  • Source-linked evidence blocks
  • Schema-ready content model
  • Investor FAQ
  • AI-search-readable summaries
  • Citation table

Comparator Failure Map

Best for

Investors, corporate strategy teams, and founders entering crowded or failed categories.

A research product that identifies what happened to related companies, platforms, indications, financing paths, and clinical programs.

Deliverables

  • Comparable company table
  • Failure-mode taxonomy
  • Financing history
  • Translational risk map
  • Lessons for the current company

At a glance

How the services compare

ServiceBest forPrimary output
HDDT SnapshotFounders, angels, accelerators, and early-stage diligence.Priority diligence questions
Investor-Readiness HDDTSeed-stage biotech companies preparing for investor conversations.Investor-facing authority report
Diligence-as-Authority PageBiotech companies, funds, university spinouts, and regional innovation groups.Citation table
Comparator Failure MapInvestors, corporate strategy teams, and founders entering crowded or failed categories.Lessons for the current company

Not sure which service fits?

Tell us the decision you are trying to make. We will recommend the right depth.